COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications

被引:109
作者
Gawalko, Monika [1 ,2 ,3 ]
Kaplon-Cieslicka, Agnieszka [1 ]
Hohl, Mathias [4 ]
Dobrev, Dobromir [5 ]
Linz, Dominik [2 ,3 ,6 ,7 ,8 ,9 ]
机构
[1] Med Univ Warsaw, Dept Cardiol 1, 1a Banacha St, PL-02097 Warsaw, Poland
[2] Maastricht Univ, Med Ctr, Dept Cardiol, Maastricht, Netherlands
[3] Cardiovasc Res Inst Maastricht, Maastricht, Netherlands
[4] Univ Saarland, Klin Innere Med 3, Homburg, Germany
[5] Univ Duisburg Essen, West German Heart & Vasc Ctr, Inst Pharmacol, Essen, Germany
[6] Univ Adelaide, Ctr Heart Rhythm Disorders, Adelaide, SA, Australia
[7] Royal Adelaide Hosp, Adelaide, SA, Australia
[8] Radboud Univ Nijmegen, Med Ctr, Dept Cardiol, Nijmegen, Netherlands
[9] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark
来源
IJC HEART & VASCULATURE | 2020年 / 30卷
基金
美国国家卫生研究院;
关键词
Anticoagulation; Arrhythmia; Inflammasome; Remote monitoring; Thromboembolic risk; OBSTRUCTIVE RESPIRATORY EVENTS; CRITICALLY-ILL PATIENTS; INFLAMMATION; OUTCOMES; DISEASE; PROMOTES; RECEPTOR; ACE2; DYSFUNCTION; AMIODARONE;
D O I
10.1016/j.ijcha.2020.100631
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronavirus disease 2019 (COVID-19) is a novel, highly transmittable and severe strain disease, which has rapidly spread worldwide. Despite epidemiological evidence linking COVID-19 with cardiovascular diseases, little is known about whether and how COVID-19 influences atrial fibrillation (AF), the most prevalent arrhythmia in clinical practice. Here, we review the available evidence for prevalence and incidence of AF in patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and discuss disease management approaches and potential treatment options for COVID-19 infected AF patients. (C) 2020 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:8
相关论文
共 95 条
[1]   Risk factors and outcomes associated with new-onset atrial fibrillation during acute respiratory distress syndrome [J].
Ambrus, Daniel B. ;
Benjamin, Emelia J. ;
Bajwa, Ednan K. ;
Hibbert, Kathryn A. ;
Walkey, Allan J. .
JOURNAL OF CRITICAL CARE, 2015, 30 (05) :994-997
[2]   The Clinical Profile and Pathophysiology of Atrial Fibrillation Relationships Among Clinical Features, Epidemiology, and Mechanisms [J].
Andrade, Jason ;
Khairy, Paul ;
Dobrev, Dobromir ;
Nattel, Stanley .
CIRCULATION RESEARCH, 2014, 114 (09) :1453-1468
[3]   Electrocardiographic features of patients with COVID-19 pneumonia [J].
Angeli, Fabio ;
Spanevello, Antonio ;
De Ponti, Roberto ;
Visca, Dina ;
Marazzato, Jacopo ;
Palmiotto, Giulia ;
Feci, Davide ;
Reboldi, Gianpaolo ;
Fabbri, Leonardo M. ;
Verdecchia, Paolo .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 78 :101-106
[4]  
[Anonymous], COR DIS 2019 COVID 1
[5]   Cardiac excitation-contraction coupling [J].
Bers, DM .
NATURE, 2002, 415 (6868) :198-205
[6]  
Bhatla A., 2020, HEART RHYTHM
[7]   Sequential activation of matrix metalloproteinase 9 and transforming growth factor β in arterial elastocalcinosis [J].
Bouvet, Celine ;
Moreau, Simon ;
Blanchette, Joannie ;
de Blois, Denis ;
Moreau, Pierre .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (05) :856-862
[8]  
CDC, COR DIS 2019 COVID 1
[9]   Oral anticoagulant use for stroke prevention in atrial fibrillation patients with difficult scenarios [J].
Chang, Ting-Yung ;
Liao, Jo-Nan ;
Chao, Tze-Fan ;
Vicera, Jennifer Jeanne ;
Lin, Chin-Yu ;
Tuan, Ta-Chuan ;
Lin, Yenn-Jiang ;
Chang, Shih-Lin ;
Lo, Li-Wei ;
Hu, Yu-Feng ;
Chung, Fa-Po ;
Chen, Shih-Ann .
IJC HEART & VASCULATURE, 2018, 20 :56-62
[10]   Cardiovascular manifestations in severe and critical patients withCOVID-19 [J].
Chen, Qingxing ;
Xu, Lili ;
Dai, Yongbin ;
Ling, Yunlong ;
Mao, Jiahao ;
Qian, Juying ;
Zhu, Wenqing ;
Di, Wencheng ;
Ge, Junbo .
CLINICAL CARDIOLOGY, 2020, 43 (07) :796-802